Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Allergan plc
Description0.05% desonide gel
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis; Treat mild to moderate atopic dermatitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today